Dengvaxia In The Philippines Pulled Out
Ringo | On 05, Dec 2017
The Food and Drug Administration ordered the Sanofi Pasteur to stop the sales of Dengvaxia.
A week ago, the Sanofi, a French company, announced that Dengvaxia may pose a serious threat to people who had not dengue, a mosquito-borne disease.
The FDA said the Sanofi should “SUSPEND the sale/distribution/marketing and cause the WITHDRAWAL” of the Dengvaxia on Monday.
After Sanofi’s admission, a nationwide uproar happened in the Philippines since more than half a million children have undergone the immunization program of the government. The project was immediately halted.
However, the vaccines are still available through private organizations until the FDA order. Sanofi was also ordered to mount information through letters, advisories and much more.
The government urged the public, especially the parents of those immunized children, not to panic but to observe their children. It is also advised to immediately report incidents that “reasonably indicates that Dengvaxia has caused or contributed to the death, serious illness, or serious injury.”